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A new era in advanced heart failure therapy. Left Ventricular Assist Device. 
 
1. The EUROMACS-RHF risk score outperforms currently known risk scores for right 
heart failure and can be useful for tailored risk-based clinical assessment and 
management of patients with advanced heart failure evaluated for left ventricular 
assist device (LVAD) therapy. (this thesis)  
 
2. The longer a patient is supported with an LVAD the more suspicious clinicians should 
be for mechanical device failure. (this thesis)  
 
3. Acute  kidney  injury  following  LVAD  implantation  is  largely  the  consequence  of  
the  deteriorating  condition  of  the  LVAD  recipient  prior  to  LVAD  implantation.  
(this  thesis) 
 
4. The impact of co-morbidities is more severe in older patients, and additional effort 
should be made to optimize their condition prior to LVAD implantation. (this thesis)  
 
5. Nearly all LVAD patients suffer from the acquired von Willebrand syndrome. 
However, a definite association with bleeding events has yet to be determined. (this 
thesis)  
 
6. The right ventricle remains the Achilles heel of LVAD therapy.  
 
7. The “destination” should be clear for destination therapy LVAD patients.  
 
8. Psychological assessment prior to LVAD implantation and psychological support post 
implantation are needed to ensure optimal quality of life during LVAD support.   
 
9. The question is not if the left ventricular assist device is going to fail, but when.   
 
10. Family is not an important thing. It’s everything. (Michael J. Fox) 
 
11. I am the wisest man alive, for I know one thing, and that is that I know nothing. 
(Plato) 
 
 
